SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer

International Journal of Oncology

Volumn 38, Issue 4, 2011, Pages 933-939

  Kobayashi, Daisuke ^a   Kuribayshi, Kageaki ^a   Tanaka, Maki ^a   Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell cycle; Early breast cancer; mRNA expression; SALL4; siRNA

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SALL4; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY CANCER; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MENOPAUSE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 79952338489     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.929     Document Type: Article

References (30)

1. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A and Jordan VC: Early breast cancer (review). Lancet 373: 1463-1479, 2009.
2. Koshida S, Kobayashi D, Moriai R, Tsuji N and Watanabe N: Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 98: 315-320, 2007. (Pubitemid 46195600)
3. Wascher RA, Huynh KT, Giuliano AE, Hansen NM, Singer FR, Elashoff D and Hoon DS: Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. Clin Cancer Res 9: 1427-1435, 2003. (Pubitemid 36418397)
4. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M and Anker P: Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6: 3823-3826, 2000.
5. Pardal R, Molofsky AV, He S and Morrison SJ: Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors (review). Cold Spring Harb Symp Quant Biol 70: 177-185, 2005. (Pubitemid 44124870)
6. Yasuda SY, Tsuneyoshi N, Sumi T, Hasegawa K, Tada T, Nakatsuji N and Suemori H: NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer. Genes Cells 11: 1115-1123, 2006. (Pubitemid 44256388)
7. Zhou Q, Chipperfield H, Melton DA and Wong WH: A gene regulatory network in mouse embryonic stem cells. Proc Natl Acad Sci USA 104: 16438-16443, 2007. (Pubitemid 350211036)
8. Zhang J, Tam WL, Tong GQ, Wu Q, Chan KY, Soh BS, Lou Y, Yang J, Ma Y, Chai L, Ng HH, Lufkin T, Robson P and Lim B: Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8: 1114-1123, 2006.
9. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, Lim CA, Robson P, Zhong S and Ng HH: A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10: 353-360, 2008. (Pubitemid 351331023)
10. Okita K, Ichisaka T and Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317, 2007. (Pubitemid 47080336)
11. Tsubooka N, Ichisaka T, Okita K, Takahashi K, Nakagawa M and Yamanaka S: Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. Genes Cells 14: 683-694, 2009.
12. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II and Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
13. Hyslop L, Stojkovic M, Armstrong L, Walter T, Stojkovic P, Przyborski S, Herbert M, Murdoch A, Strachan T and Lako M: Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 23: 1035-1043, 2005. (Pubitemid 41377718)
14. Sakaki-Yumoto M, Kobayashi C, Sato A, Fujimura S, Matsumoto Y, Takasato M, Kodama T, Aburatani H, Asashima M, Yoshida N and Nishinakamura R: The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development. Development 133: 3005-3013, 2006. (Pubitemid 44314277)
15. Jürgens G: Head and tail development of the Drosophila embryo involves spalt, a novel homeotic gene. EMBO J 7: 189-196, 1988.
16. AL-Baradie R, Yamada K, St Hilaire C, Chan WM, Andrews C, Mcintosh N, Nakano M, Martonyi EJ, Raymond WR, Okumura S, Okihiro MM and Engle EC: Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am J Hum Genet 71: 1195-1199, 2002. (Pubitemid 35305238)
17. Kohlhase J, Heinrich M, Liebers M, Fröhlich Archangelo L, Reardon W and Kispert A: Cloning and expression analysis of SALL4, the murine homologue of the gene mutated in Okihiro syndrome. Cytogenet Genome Res 98: 274-277, 2002. (Pubitemid 37499859)
18. Ma Y, Cui W, Yang J, Qu J, Di C, Amin HM, Lai R, Ritz J, Krause DS and Chai L: SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood 108: 2726-2735, 2006.
19. Cui W, Kong NR, Ma Y, Amin HM, Lai R and Chai L: Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. Mod Pathol 19: 1585-1592, 2006. (Pubitemid 44789927)
20. Yang J, Chai L, Gao C, Fowles TC, Alipio Z, Dang H, Xu D, Fink LM, Ward DC and Ma Y: SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood 112: 805-813, 2008.
21. Yang J, Chai L, Liu F, Fink LM, Lin P, Silberstein LE, Amin HM, Ward DC and Ma Y: Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc Natl Acad Sci USA 104: 10494-10499, 2007. (Pubitemid 47185693)
22. Dimri GP, Martinez JL and Jacobs JJ, et al: The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62: 4736-4745, 2002.
23. Liu L, Andrews LG and Tollefsbol TO: Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death. Oncogene 25: 4370-4375, 2006. (Pubitemid 44100507)
24. Cao D, Li J, Guo CC, Allan RW and Humphrey PA: SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol 33: 1065-1077, 2009.
25. Cao D, Humphrey PA and Allan RW: SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 115: 2640-2651, 2009.
26. Cao D, Guo S, Allan RW, Molberg KH and Peng Y: SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 33: 894-904, 2009.
27. Wu Q, Chen X, Zhang J, Loh YH, Low TY, Zhang W, Zhang W, Sze SK, Lim B and Ng HH: Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem 281: 24090-24094, 2006. (Pubitemid 44274183)
28. Nirasawa S, Kobayashi D, Tsuji N, Kuribayashi K and Watanabe N: Diagnostic relevance of overexpressed Nanog gene in early lung cancers. Oncol Rep 22: 587-591, 2009.
29. Bard JD, Gelebart P, Amin HM, Young LC, Ma Y and Lai R: Signal transducer and activator of transcription 3 is a transcriptional factor regulating the gene expression of SALL4. FASEB J 23: 1405-1414, 2009.
30. Saeki M, Kobayashi D, Tsuji N, Kuribayashi K and Watanabe N: Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers. Int J Oncol 35: 511-515, 2009.